IDH1 and astrocytoma (excluding glioblastoma): This proportion is slightly higher than that observed in the TCGA cohort (21.7%), although both values are consistent with previous reports of a 20–30% prevalence in IDH-mutant astrocytomas [3] and with the high frequency of this mutation in brain tissue (Figure 3b).